Research Author

Yu Du

Eli Lilly (United States)
Yale University

ORCID OpenAlex profile

0Studies tracked

0Claims cite

0Videos use

Average study score: 61/100

Bibliography

Studies by this author

1 study attributed to Yu Du on the platform. Click a card to read the full analysis.

Study

Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.

The study aimed to evaluate the efficacy, safety, and dose-response relationships of retatrutide, a triple hormone-receptor agonist, for the treatment of obesity in adults over 48 weeks.

Mod-High

Ania M. Jastreboff,Lee M. Kaplan,Juan P. Frías+7 more

Eli Lilly (United States)

Read analysis